amycretin vs retatrutide in obesity: Mechanisms, clinical efficacy, and future perspectives - Metabolism NEW GLP1 Amycretin VS Retatrutide

Wang et al., 2024)

Neuroscience 202, 396404

Some clinical data suggests the fat-to-lean loss ratio can reach 85:15 or even 90:10 with optimal training protocols

For patients using GLP-1 agonists primarily for weight management rather than diabetes control, temporary adjustment typically poses less immediate concern regarding blood glucose levels

Considering all factors, many patients achieve their desired outcomes, and yes, they can sustain positive results when they pair healthy eating habits and regular activity with taking these weight loss medications

Its better than any diet pill or diet! Linda Pearcy Goiter has been tormenting me for three years